Clinical Epidemiology and Health Services Research
临床流行病学和卫生服务研究
基本信息
- 批准号:8080967
- 负责人:
- 金额:$ 15.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdherenceAmericanAnti-Retroviral AgentsApplications GrantsBehavioralBiometryCardiovascular DiseasesClinicalClinical DataClinical ResearchCollaborationsCollectionDataData SourcesDevelopmentDiseaseDisease ManagementEffectivenessElectronicsEpidemiologistFosteringFundingGoalsHIVHIV InfectionsHealth ServicesHealth Services ResearchHealthcareHepatitis C virusHuman ResourcesInfectionInformation SystemsInternationalLinkLipodystrophyMeasuresMental DepressionMental HealthMetabolicMulti-Drug ResistanceOutcomeOutcomes ResearchPatientsPersonsPopulationPopulations at RiskPostdoctoral FellowRegistriesResearchResearch DesignResearch MethodologyResearch PersonnelResearch SupportResourcesRetrovirologyScientistSiteSourceSpecimenStudentsStudy SubjectSubstance abuse problemSystemTechnologyTrainingTranslational ResearchTreatment EfficacyTreatment outcomeUniversitiesWashingtonantiretroviral therapybaseclinical epidemiologyclinical practicecohortdrug resistant virusexperienceinterdisciplinary approachmeetingspatient registryrepositoryresearch studytranslational study
项目摘要
The goals of the UW CFAR Clinical Epidemiology and Health Services Research Core (CE&HSR) (formally
Health Services Research Core) are to support clinical and translational HIV/AIDS research by UW CFARaffiliated
investigators by providing longitudinal HIV/AIDS patient information and expertise in clinical
epidemiology and health services research methods; and to foster interdisciplinary approaches to questions
concerning HIV/AIDS by facilitating collaborations between clinician researchers, epidemiologists, health
services researchers, biostatisticians, behavioral, and basic scientists. A main goal of the Core is to promote
clinical HIV/AIDS research examining the long-term outcomes of HIV-infected patients in routine clinical
practice, including the effects of antiretroviral therapy, co-morbid conditions, and complications of treatment.
Additional goals of the Core are to support the conduct of interventional studies and to facilitate translational
research by supplying clinical patient data linked to specimens collected on the HIV-infected population.
At the start of its fifth year of the current funding cycle, the CE&HSR Core has accomplished and
exceeded the goals set forth in our last application. The UWHIS has been expanded to capture new data
types to support research on key HIV subpopulations. The Core maintains a registry of HIV-infected patients
who are willing to participate in research studies and supports researchers preparing grant applications by
identifying registry patients who meet proposed study criteria, providing lists of potential study subjects for
recruitment, and addressing questions concerning clinical outcomes for persons with HIV/AIDS. The
CE&HSR Core provides support to the UW HIV Specimen Repository and collaborates with the Clinical
Research, Developmental, Biometrics, and Clinical Retrovirology cores to support new investigator
awardees, clinical outcomes research, and translational research. Core personnel have been active in
national and international cohort collaborations such as the CFAR Network of Integrated Clinical Systems
(CNICS) and the North American region of the (IEDEA) project, the North American AIDS Cohort
Collaboration on Research and Design (NA-ACCORD). Finally, Core resources are being used to implement
technology to facilitate the collection of new patient-based measures on adherence, lipodystrophy,
depression, HRQL, and substance abuse.
UW CFAR临床流行病学和卫生服务研究核心(CE&HSR)的目标(正式
卫生服务研究核心)是支持临床和转化艾滋病毒/艾滋病研究的UW CFR附属
研究人员通过提供纵向艾滋病毒/艾滋病患者的信息和专业知识,
流行病学和卫生服务的研究方法;并促进跨学科的方法来解决问题
通过促进临床研究人员、流行病学家、卫生保健工作者、
服务研究人员、生物统计学家、行为和基础科学家。核心的一个主要目标是促进
艾滋病毒/艾滋病临床研究,检查艾滋病毒感染者在常规临床
这一做法,包括抗逆转录病毒治疗的影响,共病条件,和治疗的并发症。
核心的其他目标是支持进行干预性研究,并促进转化
通过提供与从艾滋病毒感染人群中收集的标本相关的临床患者数据,开展研究。
在当前资金周期的第五年开始时,CE&HSR核心已经完成,
超过了我们上次申请的目标UWHIS已扩展到捕获新数据
支持对艾滋病毒主要亚群的研究。该中心对艾滋病毒感染者进行登记
谁愿意参与研究,并支持研究人员准备拨款申请,
确定符合拟定研究标准的登记研究患者,提供潜在研究受试者列表,
招募和处理有关艾滋病毒/艾滋病患者临床结果的问题。的
CE&HSR核心为UW HIV标本库提供支持,并与临床
支持新研究者的研究、开发、生物统计学和临床逆转录病毒学核心
获奖者,临床结果研究和转化研究。核心人员一直活跃在
国家和国际队列合作,如CFAR综合临床系统网络
(CNICS)和北美区域(IEDEA)项目,北美艾滋病队列
研究与设计合作(NA-ACCORD)。最后,核心资源正用于实施
技术,以促进收集新的基于患者的措施,坚持,脂肪代谢障碍,
抑郁症HRQL和药物滥用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARI M KITAHATA其他文献
MARI M KITAHATA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARI M KITAHATA', 18)}}的其他基金
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
- 批准号:
8211460 - 财政年份:2011
- 资助金额:
$ 15.87万 - 项目类别:
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
- 批准号:
8333978 - 财政年份:2011
- 资助金额:
$ 15.87万 - 项目类别:
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
- 批准号:
8527634 - 财政年份:2011
- 资助金额:
$ 15.87万 - 项目类别:
Clinical Epidemiology and Health Services Research
临床流行病学和卫生服务研究
- 批准号:
7479032 - 财政年份:2008
- 资助金额:
$ 15.87万 - 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
- 批准号:
6147585 - 财政年份:2000
- 资助金额:
$ 15.87万 - 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
- 批准号:
6631671 - 财政年份:2000
- 资助金额:
$ 15.87万 - 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
- 批准号:
6372702 - 财政年份:2000
- 资助金额:
$ 15.87万 - 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
- 批准号:
6510209 - 财政年份:2000
- 资助金额:
$ 15.87万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 15.87万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 15.87万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 15.87万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 15.87万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 15.87万 - 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
- 批准号:
03660315 - 财政年份:1991
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 15.87万 - 项目类别: